{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T07:35:17Z","timestamp":1660116917142},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2442,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.exphem.2015.05.011","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T12:06:09Z","timestamp":1434197169000},"page":"880-890","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Expression of the ETS transcription factor GABP\u03b1 is positively correlated to\u00a0the BCR-ABL1\/ABL1 ratio in CML patients and affects imatinib sensitivity in\u00a0vitro"],"prefix":"10.1016","volume":"43","author":[{"given":"Georgi","family":"Manukjan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Ripperger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Santer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"von Neuhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Schambach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Schlegelberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Steinemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2015.05.011_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.011_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0092-8674(91)90521-Y","article-title":"The BCR gene encodes a novel serine\/threonine kinase activity within a single exon","volume":"67","author":"Maru","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.011_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2015.05.011_bib4","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.011_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.011_bib6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ajh.23282","article-title":"Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management","volume":"87","author":"Jabbour","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2015.05.011_bib7","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.011_bib8","first-page":"970","article-title":"Erythropoietin promotes resistance against the Abl tyrosine kinase inhibitor imatinib (STI571) in K562 human leukemia cells","volume":"1","author":"Kirschner","year":"2003","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.exphem.2015.05.011_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-8722-4-6","article-title":"BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance","volume":"4","author":"Quentmeier","year":"2011","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2015.05.011_bib10","doi-asserted-by":"crossref","first-page":"724360","DOI":"10.1155\/2013\/724360","article-title":"Emerging therapeutic strategies for targeting chronic myeloid leukemia stem cells","volume":"2013","author":"Hamad","year":"2013","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.exphem.2015.05.011_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bcmd.2003.09.005","article-title":"GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions","volume":"32","author":"Rosmarin","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.exphem.2015.05.011_bib12","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1101\/gad.6.12b.2502","article-title":"Specificities of protein\u2013protein and protein\u2013DNA interaction of GABP alpha and two newly defined ets-related proteins","volume":"6","author":"Brown","year":"1992","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2015.05.011_bib13","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1093\/nar\/24.24.4954","article-title":"Functional domains of transcription factor hGABP beta1\/E4TF1-53 required for nuclear localization and transcription activation","volume":"24","author":"Sawa","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2015.05.011_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1126\/science.279.5353.1037","article-title":"The structure of GABPalpha\/beta: an ETS domain-ankyrin repeat heterodimer bound to DNA","volume":"279","author":"Batchelor","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.exphem.2015.05.011_bib15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/ni1117","article-title":"GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells","volume":"5","author":"Xue","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2015.05.011_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.immuni.2007.03.010","article-title":"The transcription factor GABP is a critical regulator of B lymphocyte development","volume":"26","author":"Xue","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2015.05.011_bib17","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2010-07-298802","article-title":"GABP transcription factor is required for myeloid differentiation, in part, through its control of Gfi-1 expression","volume":"118","author":"Yang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.011_bib18","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2010-09-306563","article-title":"GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem\/progenitor cells","volume":"117","author":"Yu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.011_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.stem.2012.05.021","article-title":"Targeting tetramer-forming GABPbeta isoforms impairs self-renewal of hematopoietic and leukemic stem cells","volume":"11","author":"Yu","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2015.05.011_bib20","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1073\/pnas.1212904110","article-title":"GABP transcription factor is required for development of chronic myelogenous leukemia via its control of PRKD2","volume":"110","author":"Yang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.011_bib21","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.011_bib22","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/sj.leu.2401566","article-title":"Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR","volume":"13","author":"Emig","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.011_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","article-title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","volume":"108","author":"Hughes","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.011_bib24","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/sj.gt.3302807","article-title":"Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors","volume":"13","author":"Schambach","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.exphem.2015.05.011_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood-2001-11-0042","article-title":"Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates","volume":"100","author":"Sandrin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.011_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gene.2009.04.005","article-title":"Identification of a minimal cis-element and cognate trans-factor(s) required for induction of Rac2 gene expression during K562 cell differentiation","volume":"440","author":"Muthukrishnan","year":"2009","journal-title":"Gene"},{"key":"10.1016\/j.exphem.2015.05.011_bib27","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.celrep.2013.04.020","article-title":"The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense","volume":"3","author":"Wu","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2015.05.011_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ncb1548","article-title":"The Ets transcription factor GABP is required for cell-cycle progression","volume":"9","author":"Yang","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.011_bib29","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1021\/bi002649m","article-title":"Neuregulin-1-stimulated phosphorylation of GABP in skeletal muscle cells","volume":"40","author":"Fromm","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.exphem.2015.05.011_bib30","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1074\/jbc.273.17.10112","article-title":"The GABP-responsive element of the interleukin-2 enhancer is regulated by JNK\/SAPK-activating pathways in T lymphocytes","volume":"273","author":"Hoffmeyer","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.05.011_bib31","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.4049\/jimmunol.174.8.4613","article-title":"Rac2 regulates neutrophil chemotaxis, superoxide production, and myeloid colony formation through multiple distinct effector pathways","volume":"174","author":"Carstanjen","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2015.05.011_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ccr.2007.10.015","article-title":"Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease","volume":"12","author":"Thomas","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.011_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood-2009-10-247437","article-title":"Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in\u00a0vivo","volume":"116","author":"Sengupta","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.011_bib34","doi-asserted-by":"crossref","first-page":"e49892","DOI":"10.1371\/journal.pone.0049892","article-title":"The ETS transcription factors ELK1 and GABPA regulate different gene networks to control MCF10A breast epithelial cell migration","volume":"7","author":"Odrowaz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2015.05.011_bib35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nmeth.1246","article-title":"Genome-wide analysis of transcription factor binding sites based on ChIP-Seq data","volume":"5","author":"Valouev","year":"2008","journal-title":"Nat Methods"},{"key":"10.1016\/j.exphem.2015.05.011_bib36","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.1158\/0008-5472.CAN-04-0981","article-title":"Protein kinase D2 mediates activation of nuclear factor kappaB by Bcr-Abl in Bcr-Abl+ human myeloid leukemia cells","volume":"64","author":"Mihailovic","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2015.05.011_bib37","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/ng.219","article-title":"A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia","volume":"40","author":"Di Bernardo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.011_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0962-8924(02)02262-6","article-title":"Protein kinase D: an intracellular traffic regulator on the move","volume":"12","author":"Van Lint","year":"2002","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.011_bib39","doi-asserted-by":"crossref","first-page":"9400","DOI":"10.1074\/jbc.M312840200","article-title":"Bcr-Abl regulates protein kinase Ciota (PKCiota) transcription via an Elk1 site in the PKCiota promoter","volume":"279","author":"Gustafson","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.05.011_bib40","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1535-7163.MCT-09-1145","article-title":"A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in\u00a0vitro and in\u00a0vivo","volume":"9","author":"Harikumar","year":"2010","journal-title":"Mol Cancer Ther"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15001939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15001939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:05:46Z","timestamp":1654923946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X15001939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0301472X15001939"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2015.05.011","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of the ETS transcription factor GABP\u03b1 is positively correlated to\u00a0the BCR-ABL1\/ABL1 ratio in CML patients and affects imatinib sensitivity in\u00a0vitro","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2015.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}